An Update on Vaccine Roll-Out for 5-11 Year-olds in the U.S.

An Update on Vaccine Roll-Out for 5-11 Year-olds in the U.S.

December 8, 2021 | On November 2, the Centers for Disease Control and Prevention (CDC) recommended Pfizer’s COVID-19 vaccine for children, ages 5-11, in the United States, making the U.S. one of the first countries to do so. We previously discussed many of the issues to consider in rolling out pediatric COVID-19 vaccines to the 28 million 5-11 year-olds living in the U.S., including that a new formulation of the vaccine needed to be shipped for this purpose, different vaccine providers would need to be engaged, and parents and caregivers would play the determinate role in the effort, all factors suggesting that rollout might face unique issues. Now, a little more than one month since vaccines were first recommended for kids, we examine progress to date nationally and by state.